Hemant Thukral of Aditya Birla Money told CNBC-TV18, "Midcap pharma started this contract with fresh open interest adding up. It was a difficult choice between Aurobindo Pharma and Wockhardt but the reason to choose Wockhardt is that the open interest has increased up by 6 percent. Delivery volumes have started to move up and importantly the stock is now clearly trading above Rs 1,550. So, I would keep a stop loss of Rs 1,525 and I feel that in immediate short-term Rs 1,625-1,640 will be the target."At 10:57 hrs Wockhardt was quoting at Rs 1,575.30, up Rs 12.55, or 0.80 percent. It has touched an intraday high of Rs 1,584.95 and an intraday low of Rs 1,560.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!